Filter
2291
Filtered Results: 2291
Text search:
clinical
trials
Featured
Recommendations
240
New Publications
396
Language
Document type
No document type
1162
Guidelines
435
Studies & Reports
382
Manuals
103
Fact sheets
84
Strategic & Response Plan
56
Training Material
28
Situation Updates
14
Resource Platforms
12
Infographics
11
Brochures
2
Videos
2
Countries / Regions
India
112
Global
95
South Africa
53
Kenya
39
Western and Central Europe
39
Africa
38
Uganda
25
East and Southern Africa
25
Latin America and the Carribbean
25
Ethiopia
24
West and Central Africa
24
Sierra Leone
22
Russia
22
Nigeria
20
Zambia
20
Brazil
20
Liberia
18
Nepal
18
Malawi
18
Tanzania
17
Ukraine
17
Eastern Europe
17
Rwanda
16
Philippines
15
Zimbabwe
14
Germany
14
Indonesia
14
Ghana
13
Middle East and North Africa
13
Bangladesh
11
Mozambique
11
Namibia
11
South–East Asia Region
11
Congo, Democratic Republic of
10
Asia
10
Guinea
9
South Sudan
8
Peru
8
USA
7
Cameroon
7
Eastern Europe and Central Asia
7
Burkina Faso
6
Eswatini/ Swaziland
6
Botswana
6
Angola
6
Lesotho
6
Cambodia
5
Colombia
5
Chile
5
Albania
5
Thailand
4
Sudan
4
North America
4
United Kingdom
4
Senegal
3
Guinea-Bissau
3
Haiti
3
Syria
3
China
3
Argentina
3
Paraguay
3
Vietnam
3
Spain
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Pakistan
2
Iraq
2
Lebanon
2
Burundi
2
Myanmar / Burma
2
Sri Lanka
2
Laos
2
Tajikistan
2
Estonia
2
Georgia
2
France
2
Portugal
2
Morocco
1
Saudi Arabia
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Chad
1
Ireland
1
Singapore
1
Benin
1
Ecuador
1
Greece
1
Madagascar
1
Yemen
1
Western Pacific Region
1
Other region
1
Southern Africa
1
Canada
1
Bulgaria
1
Moldova
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Jamaica
1
Denmark
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
562
Clinical Guidelines
353
Public Health
154
Women & Child Health
136
Key Resources
37
Pharmacy & Technologies
34
Capacity Building
21
Toolboxes
COVID-19
305
Mental Health
291
HIV
236
TB
187
NCDs
96
NTDs
94
AMR
72
Ebola
62
Pharmacy
59
Caregiver
57
Rapid Response
56
Disability
27
Planetary Health
24
Global Health Education
22
Refugee
18
Polio
13
Conflict
13
Cholera
11
Zika
11
Health Financing Toolbox
8
Natural Hazards
4
Social Ethics
4
Specific Hazards
2
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
The 2021 COVID-19 Strategic Preparedness and Response Plan (SPRP) for AFR serves as a regional guide for a holistic public health response to COVID‑19 at regional, national and sub-national levels. The 2021
SPRP:
1. Builds upon the lessons learnt from the implementation of the 2020 SPRP and outl...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how fiv...
This issue is available in Engilsh, Maguindanao, Maranao, Tagalog from the website
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
In this edition, the Antimicrobial Resistance chapter discusses the growing, dangerous trend of antimicrobial resistance and the potential catastrophic consequences on global health.
Chapter 1 of Frontier 2017: Emerging Issues of Environmental Concern
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Tuberculosis (TB)
recommended
MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives
Learnings from the COVID-19 evidence response and recommendations for the future.
Reflections and recommendations from the evidence synthesis community.
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given that a vaccine will eventually be produced, informa...
As the world recovers from the shock of the COVID-19 pandemic and reflects on lessons learnt from failure of global public health systems to contain the global outbreak of SARS-CoV-2, new infectious disease threats, caused by movement of people globally, remain omnipresent, and repeated calls for mo...
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t...
first issued 18 August 2022
